86.0 A
KPV
Also known as: Lys-Pro-Val
Strong Clinical Evidence Research Chemical
Research Evidence 92.0/100
Safety Profile 80.0/100
54 Clinical Trials
Unknown: 3 PHASE4: 2 PHASE3: 15 PHASE2: 5 PHASE1, PHASE2: 1 PHASE1: 1 NA: 27
- Plasma Free Amino Acids in Patients With Hepatic Encephalopathy Unknown Phase UNKNOWN Assiut University
- The Impact of Selected Factors on the Cardiovascular System in Chronic Kidney Disease Unknown Phase COMPLETED Poznan University of Medical Sciences
- Pre-emptive Kidney Transplantation Quality of Life Unknown Phase COMPLETED Nantes University Hospital
- NIraparib and Quality of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib. PHASE4 COMPLETED ARCAGY/ GINECO GROUP
- Dosing Study of Amino Acids in Seriously Ill Patients PHASE4 TERMINATED Baxter Healthcare Corporation
Showing 5 of 54 trials.
19 Research Papers
- KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification Therapy. Adv Healthc Mater unknown
- Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway. Tissue Cell unknown
- Multicompartmental Hydrogel Microspheres with a Concentric Thin Oil Layer: Protecting and Targeting Therapeutic Agents for Inflammatory Bowel Disease. ACS Appl Bio Mater unknown
- Challenges in clinical nutrition research in Latin America: A narrative review. Clin Nutr ESPEN Review
- Host defense peptides as a new drug lead to a strategy for inflammatory bowel disease. Drug Discov Today Review
Showing 5 of 19 papers by citation count.
FDA Data
Not FDA-Approved
KPV has not been evaluated by the FDA for safety or efficacy. It is not approved for human therapeutic use in the United States.
Frequently Asked Questions
Is KPV FDA approved?
No, KPV has not been approved by the FDA for human therapeutic use. It is sold as a research chemical.
How many clinical trials has KPV been studied in?
KPV has been studied in 54 registered clinical trials. CheckPeptides tracks phase, status, and sponsor data for each trial.
What is the trust score for KPV?
KPV has a CheckPeptides trust score of 86.0/100 (grade: A). This score is based on clinical trial volume, research paper quality, FDA data, and evidence classification.
Last verified: April 8, 2026
Quick Facts
- Classification
- Alpha-MSH fragment
- Regulatory Status
- N/A
Score Breakdown
Research Evidence 92.0/100
Safety Profile 80.0/100
Evidence Summary
- Clinical Trials
- 54
- Research Papers
- 19
- Trust Score
- 86.0/100
- Grade
- A